Pure Global
NCT05878990

Quit & Fit 2.0: Feasibility and Usability Testing

Hackensack Meridian Health·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking Cessation
Drug/Device/Intervention
Culturally-tailored Tobacco Treatment
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Hackensack Meridian Health
Location
Nutley, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 25, 2023
End date
May 24, 2024
Enrollment
20 participants
Primary outcome

Feasibility of the 6-week tobacco treatment intervention,Accessibility and Satisfaction of the 6-week tobacco treatment intervention

Summary

Pilot randomized controlled trial to compare tobacco cessation rates of two arms: a 6-week
 culturally tailored tobacco cessation intervention versus a 6-week personalized
 culturally-tailored tobacco cessation intervention among African American women.

ICD-10 classifications
Mental and behavioural disorders due to use of tobacco withdrawal stateTobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05878990
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05878990 through Pure Global AI's free database. This phase not specified trial is sponsored by Hackensack Meridian Health and is currently Recruiting. The study focuses on Smoking Cessation. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.